{"DataElement":{"publicId":"4633600","version":"2","preferredName":"Acute Lymphoblastic Leukemia Cell Origin Type","preferredDefinition":"Text term that represents the kind of cell related to the origin of acute lymphoblastic leukemia.","longName":"4633586v1.0:4633578v1.1","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"4633586","version":"1","preferredName":"Acute Lymphoblastic Leukemia Cell Origin","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._The place where something begins or comes from in either the sense of a physical location or a metaphysical source.","longName":"2674126v1.0:4633584v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2674126","version":"1","preferredName":"ALL","preferredDefinition":"A leukemia with an acute onset, characterized by the presence of lymphoblasts or Burkitt cells in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia, precursor T lymphoblastic leukemia, and Burkitt's leukemia.","longName":"C3167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3834F55C-324A-1EBE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-21","modifiedBy":"ONEDATA","dateModified":"2007-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4633584","version":"1","preferredName":"Cell Origin","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:The place where something begins or comes from in either the sense of a physical location or a metaphysical source.","longName":"C12508:C42703","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Origin","conceptCode":"C42703","definition":"The place where something begins or comes from in either the sense of a physical location or a metaphysical source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A457525-5407-00F7-E050-BB89AD434811","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A457525-5418-00F7-E050-BB89AD434811","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/15/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4633578","version":"1.1","preferredName":"ALL Cell Origin Type","preferredDefinition":"The kind of cell associated with the origin of the acute lymphoblastic leukemia.","longName":"4633578v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T Cell ALL","valueDescription":"T-Lymphocyte Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4633579","version":"1","preferredName":"T-Lymphocyte Acute Lymphoblastic Leukemia","longName":"4633579","preferredDefinition":"A type of immune cell that can attack foreign cells, cancer cells, and cells infected with a virus. T lymphocytes can also help control immune responses. A T lymphocyte is a type of white blood cell.: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Lymphocyte","conceptCode":"C12476","definition":"A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A44E1CD-9390-6BD9-E050-BB89AD432C7A","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFB538D-884A-5D77-E053-F662850AF759","beginDate":"2014-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"B Cell ALL","valueDescription":"B-Lymphocyte Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4633580","version":"1","preferredName":"B-Lymphocyte Acute Lymphoblastic Leukemia","longName":"4633580","preferredDefinition":"Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte","conceptCode":"C12474","definition":"Immunologically important lymphocyte that is not thymus-dependent, is either short-lived and naive or long-lived and of memory phenotype, and resembles the bursa-derived lymphocyte of birds in that it is responsible for the production of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A44E1CD-93B6-6BD9-E050-BB89AD432C7A","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFB538D-8854-5D77-E053-F662850AF759","beginDate":"2014-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"Indeterminate : T vs B-Precursor","valueDescription":"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified","ValueMeaning":{"publicId":"4538437","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified","longName":"4538437","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, T/Myeloid","conceptCode":"C82213","definition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"058F579C-8D6D-3DA1-E050-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2014-10-16","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFB538D-885E-5D77-E053-F662850AF759","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"Indeterminate : B-Precursor vs Myeloid","valueDescription":"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified","ValueMeaning":{"publicId":"4538435","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified","longName":"4538435","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, B/Myeloid","conceptCode":"C82212","definition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"058F579C-8D47-3DA1-E050-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2014-10-16","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFB538D-8868-5D77-E053-F662850AF759","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"B precursor (Non-T, Non-B ALL)","valueDescription":"Pre-B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4786492","version":"1","preferredName":"Pre-B Acute Lymphoblastic Leukemia","longName":"4786492v1.00","preferredDefinition":"An acute lymphoblastic leukemia that originates from pre-B lymphocytes. The pre-B lymphoblasts contain cytoplasmic immunoglobulin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pre-B Acute Lymphoblastic Leukemia","conceptCode":"C27798","definition":"An acute lymphoblastic leukemia that originates from pre-B lymphocytes. The pre-B lymphoblasts contain cytoplasmic immunoglobulin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"134B1194-AC1D-28A7-E050-BB89AD435CC9","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFB538D-8872-5D77-E053-F662850AF759","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"B-Precursor","valueDescription":"B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4263974","version":"1","preferredName":"B Acute Lymphoblastic Leukemia","longName":"4263974","preferredDefinition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia","conceptCode":"C8644","definition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1156-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFB538D-887C-5D77-E053-F662850AF759","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"Near Early T-cell Precursor (ETP) ALL","valueDescription":"Near Early T Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"6590921","version":"1","preferredName":"Near Early T Acute Lymphoblastic Leukemia","longName":"6590921","preferredDefinition":"Not far distant in time or space or degree or circumstances.: T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Near","conceptCode":"C48927","definition":"Not far distant in time or space or degree or circumstances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Early T Precursor Acute Lymphoblastic Leukemia","conceptCode":"C130043","definition":"T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDA918-494F-35C9-E053-F662850AA2CF","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFDA918-4968-35C9-E053-F662850AA2CF","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"T-ALL, not otherwise specified (NOS)","valueDescription":"Not Otherwise Specified T Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"6590922","version":"1","preferredName":"Not Otherwise Specified T Acute Lymphoblastic Leukemia","longName":"6590922","preferredDefinition":"Not characterized in any other way.: Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Acute Lymphoblastic Leukemia","conceptCode":"C3183","definition":"Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDA918-497A-35C9-E053-F662850AA2CF","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFDA918-4993-35C9-E053-F662850AA2CF","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"T-ALL, not Early T-cell Precursor (ETP)","valueDescription":"Negation Early T Acute Lymphoblastic Leukemia T Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"6590923","version":"1","preferredName":"Negation Early T Acute Lymphoblastic Leukemia T Acute Lymphoblastic Leukemia","longName":"6590923","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.: Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Early T Precursor Acute Lymphoblastic Leukemia","conceptCode":"C130043","definition":"T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Acute Lymphoblastic Leukemia","conceptCode":"C3183","definition":"Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDBBAF-4729-5364-E053-F662850ABA26","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFDBBAF-4742-5364-E053-F662850ABA26","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"},{"value":"Early T-cell Precursor (ETP) ALL","valueDescription":"Early T Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"6590924","version":"1","preferredName":"Early T Acute Lymphoblastic Leukemia","longName":"6590924","preferredDefinition":"T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Early T Precursor Acute Lymphoblastic Leukemia","conceptCode":"C130043","definition":"T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDBBAF-474E-5364-E053-F662850ABA26","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CFDBBAF-4767-5364-E053-F662850ABA26","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFB538D-8835-5D77-E053-F662850AF759","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/15/2014 Versioned to extend max length. mc 12.14.18","administrativeNotes":"2023.8.21 Updated PV def for 'No Vaule Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650571","version":"1","longName":"ALL","context":"OCG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"ALL Cell of Origin","type":"Preferred Question Text","description":"ALL Cell of Origin","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"IF ALL, Immunophenotype at diagnosis:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDC8F7-4925-2FDC-E053-F662850A8BE4","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"KUMMEROA","dateModified":"2022-06-02","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 12/15/2014 Versioned to extend max length. mc 12.14.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}